Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.4
Consolidated Balance Sheets - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 17,002,715 $ 25,006,632
Investments 42,194,296 72,640,520
Restricted cash 192,475 192,475
Prepaid expenses and other current assets 791,616 2,365,010
Total current assets 60,181,102 100,204,637
Restricted cash 477,425 477,425
Property and equipment, net 1,613,815 2,392,696
Operating lease right of use assets 3,884,252 4,609,110
Other assets 155,346 46,385
Total assets 66,311,940 107,730,253
Current liabilities:    
Notes payable 353,323 767,938
Accounts payable 2,173,963 1,782,277
Accrued expenses 5,999,252 10,093,312
Derivative liability 36,868 133,710
Operating lease liabilities, current 1,280,863 1,136,948
Current portion of long-term debt 2,795,669 3,093,344
Total current liabilities 12,639,938 17,007,529
Long-term debt, net of debt discount 15,984,426 15,636,275
Other long-term liabilities 22,205 22,205
Operating lease liabilities, noncurrent 4,675,354 5,956,217
Total liabilities 33,321,923 38,622,226
Stockholders' equity    
Preferred stock, $0.0001 par value; 10,000,000 shares authorized, no shares issued and outstanding at December 31, 2022 and December 31, 2021. See Note 13 0 0
Common stock, $0.0001 par value; 300,000,000 shares authorized, 4,171,297 and 4,169,631 shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively 417 416
Additional paid-in capital 425,196,359 418,903,820
Accumulated deficit (392,080,667) (349,733,764)
Accumulated other comprehensive loss (126,092) (62,445)
Total stockholders’ equity 32,990,017 69,108,027
Total liabilities and stockholders’ equity $ 66,311,940 $ 107,730,253